Irreversible cyclooxygenase inhibitors
Aspirin
Triflusal (Disgren)
Adenosine diphosphate (ADP) receptor inhibitors
Clopidogrel (Plavix)
Prasugrel  (Effient)
Ticagrelor (Brilinta)
Ticlopidine (Ticlid)
Phosphodiesterase inhibitors
Cilostazol (Pletal)
Protease-activated receptor-1 (PAR-1) antagonists
Vorapaxar (Zontivity)
Glycoprotein IIB/IIIA inhibitors (intravenous use only)
Abciximab (ReoPro)
Eptifibatide (Integrilin)
Tirofiban (Aggrastat)
Adenosine reuptake inhibitors
Dipyridamole (Persantine)
Thromboxane inhibitors
Thromboxane synthase inhibitors
Thromboxane receptor antagonists
Terutroban
Aspirin
Triflusal (Disgren)
Clopidogrel (Plavix)
Prasugrel  (Effient)
Ticagrelor (Brilinta)
Ticlopidine (Ticlid)
Cilostazol (Pletal)
Vorapaxar (Zontivity)
Abciximab (ReoPro)
Eptifibatide (Integrilin)
Tirofiban (Aggrastat)
Dipyridamole (Persantine)
Thromboxane synthase inhibitors
Thromboxane receptor antagonists
Terutroban
Terutroban
Pharmacology
Neil YoungDaniel OstermayerRoss Donaldson
Privacy policy
About WikEM
Disclaimers
Antiplatelet medications
Anticoagulants
Antiarrhythmics
Thrombolytics
Anti-platelet agent reversal
Calcium channel blockers
Low molecular weight heparin
Warfarin